Sjögren’s Syndrome and Ankylosing Spondylitis Association: A Case-Based Review
- 1 November 2025
- journal article
- Published by Bentham Science Publishers Ltd. in Current Rheumatology Reviews
- Vol. 21 (5) , 535-544
Abstract
Introduction: Unlike restrictive pulmonary function and apical fibrobullous disease, diffuse interstitial lung disease is scarce in patients with ankylosing spondylitis (AS). We present a systematic review of the association between AS and SS. We also report a new case of SS revealed by interstitial lung disease in AS patients treated with tumor necrosis factor (TNF) inhibitors. Materials and methods: The systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guideline using the MEDLINE and SCOPUS databases and included case reports and case series describing the association between AS and SS. Results: There were sixty-three patients, including our case: 16 males and 47 females. The mean age was 49.2 years. The mean SpA duration was 14.1 years. The mean delay between SpA and SS was 12.8 years (0-27). SS was diagnosed after SpA in 62% of cases (n=39). It preceded SpA in 36.5% (n=23) and was concomitant with SpA in 1 case. All patients had sicca symptoms. MSGB showed focal sialadenitis grade III or grade IV in the Chisholm classification in 20 patients. Anti- nuclear antibody was positive in 75.8% of cases. Among them, anti-SSA and anti-SSB were positive in 44.4% and 35.3% of cases. Except for our patient, no patient had interstitial lung disease. SS extra glandular manifestations were reported in 12 cases. Conclusion: The occurrence of Sjögren’s syndrome is uncommon in patients with ankylosing spondylitis. This association has been reported in the literature, suggesting a pathogenetic link between these two diseases. This association should be considered in ankylosing spondylitis patients with diffuse interstitial lung disease. Knowing this association is necessary for therapeutic adjustment. Our study has some limitations. Publication bias was the major bias in our study. Indeed, we only included case reports and case series describing the association between SpA and SS. We did not search for unpublished work. Moreover, the follow-up was not specified in most included articles.Keywords
This publication has 57 references indexed in Scilit:
- New‐onset primary Sjögren's syndrome following exposure to severe acute respiratory syndrome coronavirus 2: A retrospective cohort studyRheumatology & Autoimmunity, 2024
- Anti-TNF-α-induced lupus syndromeZeitschrift für Rheumatologie, 2021
- A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren’s syndrome-related interstitial lung disease in a Chinese populationClinical Rheumatology, 2018
- Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literatureClinical Rheumatology, 2017
- Pulmonary involvement in ankylosing spondylitisClinical Rheumatology, 2006
- Sjögren’s syndrome in patients with ankylosing spondylitisClinical Rheumatology, 2006
- Coexisting ankylosing spondylitis and Sjogren’s syndrome: a case reportRheumatology International, 2005
- Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testingClinical Rheumatology, 2004
- Clinical, laboratory, radiographic, and histopathologic features of methotrexate‐associated lung injury in patients with rheumatoid arthritis. A multicenter study with literature reviewArthritis & Rheumatism, 1997
- Ankylosing Spondylitis With Subsequent Development of Rheumatoid Arthritis, Sjögren'S Syndrome, and Rheumatoid VasculitisArthritis & Rheumatism, 1978